Covered recipient · General Payments record
STEPHEN WAXMAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2019
$725.58
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2019 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $356.22 | 17 |
By paying entity
PY2019 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $115.69 | 5 |
| Radius Health, Inc. | $50.32 | 2 |
| Amarin Pharma Inc. | $38.72 | 2 |
| PFIZER INC. | $33.12 | 2 |
| Amgen Inc. | $24.04 | 1 |
| Astellas Pharma US Inc | $24.03 | 1 |
| Shire North American Group Inc | $21.59 | 1 |
| Genentech USA, Inc. | $18.21 | 1 |
| Allergan Inc. | $16.86 | 1 |
| Merck Sharp & Dohme Corporation | $13.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2019 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie, Inc. | $21.67 | 06/13/2019 | Food and Beverage | Undisputed | 01/23/2026 | 648189747 | CMS |
| AbbVie, Inc. | $24.44 | 07/11/2019 | Food and Beverage | Undisputed | 01/23/2026 | 648189749 | CMS |
| AbbVie, Inc. | $23.36 | 08/27/2019 | Food and Beverage | Undisputed | 01/23/2026 | 648189751 | CMS |
| AbbVie, Inc. | $23.58 | 09/12/2019 | Food and Beverage | Undisputed | 01/23/2026 | 648189753 | CMS |
| AbbVie, Inc. | $22.64 | 11/14/2019 | Food and Beverage | Undisputed | 01/23/2026 | 648189755 | CMS |
| Allergan Inc. | $16.86 | 05/08/2019 | Food and Beverage | Undisputed | 01/23/2026 | 671290779 | CMS |
| Amarin Pharma Inc. | $16.07 | 02/22/2019 | Food and Beverage | Undisputed | 01/23/2026 | 699088521 | CMS |
| Amarin Pharma Inc. | $22.65 | 06/05/2019 | Food and Beverage | Undisputed | 01/23/2026 | 699154363 | CMS |
| Amgen Inc. | $24.04 | 02/06/2019 | Food and Beverage | Undisputed | 01/23/2026 | 663346649 | CMS |
| Astellas Pharma US Inc | $24.03 | 05/23/2019 | Food and Beverage | Undisputed | 01/23/2026 | 655795817 | CMS |
| Genentech USA, Inc. | $18.21 | 03/06/2019 | Food and Beverage | Undisputed | 01/23/2026 | 681318389 | CMS |
| Merck Sharp & Dohme Corporation | $13.64 | 02/08/2019 | Food and Beverage | Undisputed | 01/23/2026 | 695262153 | CMS |
| PFIZER INC. | $17.26 | 06/11/2019 | Food and Beverage | Undisputed | 01/23/2026 | 672039201 | CMS |
| PFIZER INC. | $15.86 | 07/31/2019 | Food and Beverage | Undisputed | 01/23/2026 | 673029577 | CMS |
| Radius Health, Inc. | $16.87 | 01/17/2019 | Food and Beverage | Undisputed | 01/23/2026 | 683959257 | CMS |
| Radius Health, Inc. | $33.45 | 08/01/2019 | Food and Beverage | Undisputed | 01/23/2026 | 683959353 | CMS |
| Shire North American Group Inc | $21.59 | 02/15/2019 | Food and Beverage | Undisputed | 01/23/2026 | 637938387 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019
- Source files
- Dataset page · Bulk file · PY2018 , PY2019
- Generated from
- OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.